Search

Your search keyword '"Tumor proteins -- Drug therapy -- Genetic aspects"' showing total 13 results
Start Over Descriptor "Tumor proteins -- Drug therapy -- Genetic aspects"
13 results on '"Tumor proteins -- Drug therapy -- Genetic aspects"'

1. New Findings from Urals Research Center for Radiation Medicine Update Understanding of Breast Cancer (Analysis of G:c>t:a, G:c>a:t, and G:c>c:g Mutations In the tp53 Gene In Women With and Without Breast Cancer In the Long-ter

Subjects
Oncology, Experimental -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Genes -- Genetic aspects, Radiation, Cancer -- Genetic aspects -- Research, Breast cancer -- Genetic aspects -- Drug therapy, Physical fitness, Health
Abstract

2024 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Oncology - Breast Cancer are presented in a new [...]

Published
2024

2. Mutant p53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic Cancer

Subjects
Tumor proteins -- Drug therapy -- Genetic aspects, Disease susceptibility -- Drug therapy -- Genetic aspects, Physical fitness, Pancreatic cancer -- Genetic aspects -- Drug therapy, Health
Abstract

2024 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2024

3. New Non-Small Cell Lung Cancer Findings from Zhejiang University Described (Concordance of Abundance for Mutational EGFR and Co-Mutational TP53 with Efficacy of EGFR-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer)

Subjects
Tumor proteins -- Drug therapy -- Genetic aspects, Metastasis -- Genetic aspects -- Drug therapy, Lung cancer, Small cell -- Drug therapy -- Genetic aspects, Lung cancer, Non-small cell -- Drug therapy -- Genetic aspects, Physical fitness -- Reports, Epidermal growth factor -- Reports -- Genetic aspects, Health
Abstract

2023 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on non-small cell lung cancer is the subject of a [...]

Published
2023

4. University of Ulsan College of Medicine Researchers Further Understanding of Cancer (p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations)

Subjects
Oncology, Experimental -- Genetic aspects, Gene mutations -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Genetic research -- Genetic aspects, Genes -- Genetic aspects, Cancer -- Genetic aspects -- Research, Biological markers -- Genetic aspects, Health
Abstract

2022 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on cancer have been presented. According to news reporting from the [...]

Published
2022

5. United States : Researchers restore function in a gene that can suppress liver cancer and enhance immunotherapy

Subjects
Oncology, Experimental -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Genetic research -- Genetic aspects, Genes -- Genetic aspects, Immunotherapy, Cancer -- Care and treatment -- Genetic aspects -- Research, Liver cancer -- Genetic aspects -- Drug therapy, RNA -- Genetic aspects, Vaccines, Business, international, Massachusetts General Hospital
Abstract

A team of researchers from Massachusetts General Hospital (MGH) and Brigham and Womens Hospital (BWH) has reprogrammed the tumor microenvironment of liver cancer by using mRNA nanoparticles. This technology, similar [...]

Published
2022

6. Research from Institute for Cancer Research and Treatment (IRCCS) Provides New Insights into Lung Cancer

Subjects
Oncology, Experimental -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Genes -- Genetic aspects, Cancer -- Care and treatment -- Genetic aspects -- Research, Lung cancer -- Drug therapy -- Genetic aspects, RNA -- Genetic aspects, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

'FHIT and p53 are the two most commonly altered tumor suppressor genes in lung cancer, and their molecular status regulates sensitivity to anticancer drugs. Although their functions are independent, there [...]

Published
2012

7. Research from Zhejiang University, Institute of Pharmacology and Toxicology broadens understanding of cancer gene therapy

Subjects
Tumor proteins -- Drug therapy -- Genetic aspects, Genetic research, Gene therapy, Cancer -- Care and treatment -- Genetic aspects -- Research -- Drug therapy, Oncology, Experimental, Communicable diseases -- Drug therapy -- Genetic aspects, Drugs, Respiratory tract infections -- Drug therapy -- Genetic aspects, Lung cancer, Non-small cell -- Drug therapy -- Genetic aspects, Universities and colleges, Biotechnology industry, Health, Science and technology
Abstract

Research findings, 'P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549,' are discussed in a new report. 'In previous [...]

Published
2010

8. Research results from University of Medicine and Dentistry of New Jersey, Cancer Institute of New Jersey update understanding of ataxia telangiectasia

Subjects
University of Medicine and Dentistry of New Jersey, Oncology, Experimental -- Drug therapy -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Ataxia -- Drug therapy -- Genetic aspects, Ataxia telangiectasia -- Drug therapy -- Genetic aspects, Cancer -- Drug therapy -- Genetic aspects -- Research, Universities and colleges -- Genetic aspects
Abstract

Data detailed in 'Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations' have been presented (see also Ataxia Telangiectasia). According to [...]

Published
2007

9. Introgen Presents Biomarker Data Demonstrating Abnormal p53 Predicts ADVEXIN Efficacy in Head and Neck, Lung, Prostate and Li-Fraumeni Cancers

Subjects
Introgen Therapeutics Inc., Advexin (Medication), Medical research -- Genetic aspects, Medicine, Experimental -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Biotechnology industry -- Genetic aspects, Cancer -- Genetic aspects -- Care and treatment
Abstract

Introgen Therapeutics, Inc. (NASDAQ:INGN) reported the results of new data analysis from multiple Phase 2 clinical studies showing a statistically significant correlation between the abnormal p53 biomarker and tumor response [...]

Published
2007

10. Research from University of Medicine and Dentistry of New Jersey, Cancer Institute of New Jersey in the area of cancer gene therapy published

Subjects
Drug therapy, Genetic aspects, Cancer treatment -- Genetic aspects, Cancer genetics -- Drug therapy -- Genetic aspects, Genetic research -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Gene therapy -- Genetic aspects, Cancer -- Drug therapy -- Genetic aspects, Cancer research -- Drug therapy -- Genetic aspects, Oncology, Experimental -- Drug therapy -- Genetic aspects, Cancer -- Care and treatment -- Genetic aspects -- Drug therapy -- Research
Abstract

Scientists discuss in 'Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53' new findings in cancer gene therapy. According to recent research published in the [...]

Published
2007

11. Hematopoietic tumor treatment should involve developing therapies that target HAUSP

Subjects
Tumors -- Drug therapy -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Ubiquitin, Cancer -- Care and treatment, Health, Science and technology, Drug therapy, Genetic aspects
Abstract

Developing therapies that target HAUSP could be used to treat hematopoietic tumors. According to recent research from South Korea, "P53, one of the most important tumor suppressor proteins, plays an [...]

Published
2006

12. Hematopoietic tumor treatment should involve developing therapies that target HAUSP

Subjects
Tumors -- Drug therapy -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Ubiquitin, Cancer -- Care and treatment, Health, Drug therapy, Genetic aspects
Abstract

Developing therapies that target HAUSP could be used to treat hematopoietic tumors. According to recent research from South Korea, "P53, one of the most important tumor suppressor proteins, plays an [...]

Published
2006

13. Combined gene therapy regimens demolish cancer proliferation

Subjects
Drug therapy, Genetic aspects, Cancer treatment -- Genetic aspects, Genetic research -- Genetic aspects, Cancer genetics -- Drug therapy -- Genetic aspects, Tumor proteins -- Drug therapy -- Genetic aspects, Gene therapy -- Genetic aspects, Cancer -- Drug therapy -- Genetic aspects, Cancer research -- Drug therapy -- Genetic aspects, Genetic transformation -- Genetic aspects, Prostate cancer -- Drug therapy -- Genetic aspects, Oncology, Experimental -- Drug therapy -- Genetic aspects, Cancer -- Genetic aspects -- Care and treatment -- Drug therapy -- Research
Abstract

Combined gene therapy regimens demolish cancer proliferation. According to scientists writing in the journal Molecular Cancer Therapeutics, 'our recent studies showed that antisense oligodeoxynucleotide targeting antiapoptotic gene, clusterin, enhanced apoptosis [...]

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results